Quebecor (TSE:QBR.B – Get Free Report) had its target price decreased by research analysts at Scotiabank from C$38.00 to C$37.00 in a research note issued to investors on Tuesday,BayStreet.CA reports. Scotiabank’s price objective indicates a potential upside of 14.48% from the company’s current price.
Several other equities research analysts also recently commented on QBR.B. BMO Capital Markets lifted their target price on shares of Quebecor from C$35.00 to C$37.00 in a research report on Thursday, September 5th. Royal Bank of Canada cut their price target on shares of Quebecor from C$38.00 to C$37.00 in a report on Friday, November 8th. TD Securities reduced their price objective on shares of Quebecor from C$40.00 to C$39.00 and set a “buy” rating on the stock in a research note on Friday, November 8th. Finally, CIBC raised their target price on Quebecor from C$39.00 to C$40.00 in a research report on Friday, November 8th. Three equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Quebecor has a consensus rating of “Moderate Buy” and a consensus target price of C$37.94.
Check Out Our Latest Stock Analysis on Quebecor
Quebecor Stock Performance
About Quebecor
Quebecor Inc operates in the telecommunications, media, and sports and entertainment businesses in Canada. Its Telecommunications segment offers television distribution, Internet access, business solutions, cable and mobile telephony, and over-the-top video services; and engages in the rental of movies, televisual products, and video games through its video-on-demand service and video rental stores.
Recommended Stories
- Five stocks we like better than Quebecor
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What Are Dividend Champions? How to Invest in the Champions
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Calculate Options Profits
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Quebecor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quebecor and related companies with MarketBeat.com's FREE daily email newsletter.